Gene Editing Improves Prostate Cancer Survival, Study in Mice Shows

Gene Editing Improves Prostate Cancer Survival, Study in Mice Shows
A new therapy targeting genomic rearrangements, such as fused genes that promote tumor development, significantly improved survival in mice with aggressive forms of prostate and liver cancer. The study,Targeting genomic rearrangements in tumor cells through Cas9-mediated insertion of a suicide gene,” was published in the journal Nature Biotechnology. “This is the first time that gene editing has been used to specifically target cancer fusion genes. It is really exciting because it lays the groundwork for what could become a totally new approach to treating cancer,” the study's lead author, Dr. Jian-Hua Luo, said in a
Subscribe or to access all post and page content.